Uproleselan Uses, Dosage, Side Effects and more
Uproleselan is under investigation in clinical trial NCT02306291 (Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML).
| Trade Name | Uproleselan |
| Generic | Uproleselan |
| Uproleselan Other Names | Uproleselan |
| Type | |
| Formula | C60H109N3O27 |
| Weight | Average: 1304.526 Monoisotopic: 1303.724845262 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
